News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Adriana Matutino Kahn

Articles by Adriana Matutino Kahn

13 Assessing Intratumor Heterogeneity in Programmed Death-Ligand 1 (PD-L1) Protein Expression in Early-Stage Breast Cancer

ByAdriana Matutino Kahn,Reza Golestani,Malini Harigopal,Lajos Pusztai, MD, DPhil

April 18th 2022

Latest Updated Articles

13 Assessing Intratumor Heterogeneity in Programmed Death-Ligand 1 (PD-L1) Protein Expression in Early-Stage Breast Cancer
Published: April 18th 2022 | Updated:

Trending on CancerNetwork

FDA Approves Revumenib in R/R NPM1-Mutant AML

FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma

Awareness Fuels Progress: Upcoming Advances in Breast Cancer Treatment

FDA Grants Fast Track Designation to MT-125 in Glioblastoma

FDA Grants BTD to Zenocutuzumab in NRG1+ Cholangiocarcinoma

© 2025 MJH Life Sciences^®

All rights reserved.